Artemis combines advanced AI-driven molecular discovery with scientific expertise to identify and pursue promising therapeutic opportunities. By leveraging its proprietary technology, the company is exploring high-value molecular targets associated with cancer, with the goal of developing novel small-molecule therapeutics.

The following six targets represent areas of research interest across a range of oncology indications, from prostate cancer to solid tumours and hematopoietic malignancies.